Anticoagulation Dilemma in a Patient With Pulmonary Embolism and Massive Haemoptysis.
- 1Adult Cardiology, Uganda Heart Institute, Kampala, UGA.
Abstract
The development of worsening haemoptysis in a patient with pulmonary embolism presents a significant treatment challenge, especially in a low-resource setting where advanced interventions such as bronchial artery embolization may not be readily available. We present the case of a 40-year-old morbidly obese woman who was transferred to our facility with recurrent lower-limb deep vein thrombosis and a new diagnosis of bilateral pulmonary embolism. Following initiation of oral anticoagulation with apixaban, she developed worsening haemoptysis that persisted despite dose adjustments. She was subsequently stabilized and discharged on a vitamin K antagonist (warfarin). This case highlights the clinical challenges encountered in managing anticoagulation in the setting of significant bleeding and underscores the importance of individualized anticoagulation therapies.
Related
- Effects of mechanical thrombectomy combined with anticoagulation vs anticoagulation monotherapy for acute intermediate-high risk pulmonary embolism: study protocol for a randomized controlled trial (CAPE study, ChiCTR2500095253, https://www.medicalresearch.org.cn/clinicalResearch/researchInfo?id=c57630b7-51ec-4b24-83e1-85b9c0a835d6).
- Renal vein thrombosis with inferior vena cava extension and pulmonary embolism in a patient with acute pyelonephritis: a case report and updated literature review
- A case report of pulmonary embolism following endoscopic cervical discectomy in an elderly patient with cervical disc herniation
- Patient Selection and Evidence for Intervention in Deep Vein Thrombosis and Pulmonary Embolism
- Pituitary Apoplexy Complicated by Pulmonary Embolism in a Neurologically Complex Patient: A Diagnostic Challenge.
BibTeX
@article{mugwano2026anticoagulation,
title = {{Anticoagulation Dilemma in a Patient With Pulmonary Embolism and Massive Haemoptysis.}},
author = {Isaac Mugwano and Faith Atim Emilly and Isaac Ssinabulya and David Salama Kaishusha and Joanita Nalyazi},
journal = {Cureus},
year = {2026},
month = sep,
doi = {10.7759/cureus.116889},
url = {https://europepmc.org/article/MED/42928820},
note = {CC BY},
}
RIS
TY - JOUR
TI - Anticoagulation Dilemma in a Patient With Pulmonary Embolism and Massive Haemoptysis.
AU - Isaac Mugwano
AU - Faith Atim Emilly
AU - Isaac Ssinabulya
AU - David Salama Kaishusha
AU - Joanita Nalyazi
PY - 2026
DA - 2026/09/25
JO - Cureus
DO - 10.7759/cureus.116889
UR - https://europepmc.org/article/MED/42928820
AB - The development of worsening haemoptysis in a patient with pulmonary embolism presents a significant treatment challenge, especially in a low-resource setting where advanced interventions such as bronchial artery embolization may not be readily available. We present the case of a 40-year-old morbidly obese woman who was transferred to our facility with recurrent lower-limb deep vein thrombosis and a new diagnosis of bilateral pulmonary embolism. Following initiation of oral anticoagulation with apixaban, she developed worsening haemoptysis that persisted despite dose adjustments. She was subsequently stabilized and discharged on a vitamin K antagonist (warfarin). This case highlights the clinical challenges encountered in managing anticoagulation in the setting of significant bleeding and underscores the importance of individualized anticoagulation therapies.
SN - 2168-8184
ER -